Therapeutic effects of antibodies to int erleukin-5

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 45, 1998, Pages 89-92

  Cuss, F M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergy; Asthma; Interleukin 5; Monoclonal antibodies

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; MONOCLONAL ANTIBODY;

ALPHA CHAIN; ASTHMA; CONFERENCE PAPER; CYTOKINE PRODUCTION; EOSINOPHILIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; HUMANS; INTERLEUKIN-5; RESPIRATORY HYPERSENSITIVITY;

EID: 0031669665     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04947.x     Document Type: Conference Paper

References (46)

1. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2- like bronchoalveolar T-lymphocyte population in atopic asthma. N Engi J Med 1992;326:298-304.
2. Marinj M, Avoni E, Hollemborg J, Mattoli S. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 1992;102:661-9.
3. Sedgwick JB, Calhoun WC, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144:1274-81.
4. Garlisi CG, Falcone A, Kung 'fJ', et al. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995;75:75-83.
5. Garlisi CG, Falcone A, Billah MM, Egan RW, Umland SP. T cells are the predominant source of interleukin-5 but not interleukin-4 mRNA in the lungs of antigen-challenged allergic mice. Am J Respir Cell Mol Biol 1996;15:420-8.
6. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151:3853-65.
7. Brinkmann V, Kristofic C. Regulation by corticosteroids of ml and Th2 cytokine production in human CD4 effector T cells generated from CD45R0 and CD45RO, subsets. J Immunol 1995;155:3322-8.
8. Umland SP, Nahrebne DK, Razac S. et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL-S and IFN-y production by cultured primary CD4 T cells. I Allergy Clin Immunol 1997;100:511-19.
9. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-ycytokine gene expression. Am Rev Respir Dis 1993; 148:401-6.
10. Krouwels PH, van der Heijden JF Lutter R, van Neerven I, Jansen HM, Out TA. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Thi profile through two mechanisms. Am I Respir Cell Mol Biol 1996;14:388-97.
11. Takahashi T, Yamaguchi N, Mita S, et al. Structural comparison of murine T-cell (B151K12)-derived T-cellreplacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity. Mol Immunol 1990;27:911-20.
12. Tavernier J, Devos R, Cornellia S. et al. A human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5 specific a chain and chain shared with the receptor for GM-CSF Cell 1991;66:1175-84.
13. Murata Y, Takaki 5, Migita M, Kikuchi Y, Tominaga A, Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 1992;175:341-51.
14. Miyajinia A, Kitamura T, Harada N, Yokota T, Aria KI. Cytokine receptors and signal transduction. Annu Rev Immunol 1992;10:295-331.
15. Silvennoinen 0, Witthuhn BA, Quelle FW, Cleveland JL, Taolin Y, Ihle IN. Structure of the murine Jak2 proteintyrosine kinase and its role in interleukin 3 signal transduction. Proc NatI Acad Sci U S A 1993;90:8429-33.
16. Mui AL-F, Wakao H, O'Farrell A-M, Harada N, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologues. EMBO J 1995;14:11l6-75.
17. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy [985:13:411-18.
18. Wardlaw AJ, Dunnett S, Gleich GJ, Collins IV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
19. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-Active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993;147:901-7.
20. Shi H, Qin S, Huang G, et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997;16:220-4.
21. Hamid Q, Azzaw M, Ying S. et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J din Invest 1991;87:1541-6.
22. Robinson DS, Ying S. Bently AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in asthma. J Allergy Clin Immunol 1993;92:397-403.
23. Motojima S, Akutsu I, Fukuda T Makino S. Takatsu K. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993;48:98-106.
24. Sur S. Gleich GJ, Swanson MC, Bartemes KR, Broide DH. Eosinophilic inflammation is associated with the elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Irnmunol 1995;96:661-8.
25. Corrigan CJ, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am Rev Respir Dis 1993;147:540-7.
26. Kosmas EN, Polychronaki A, Adamidou A, et al. Theophylline-induced down-regulation of circulating cytokines in young asymptomatic asthmatics. Am J Respir Crit Care Med 1996;153:A805.
27. Kung TI', Stelts DM, Zurcher JA, et al. Involvement of IL- 5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am 3 Respir Cell Mol Biol 1995;13:360-5.
28. Foster PS, Hogan SP, Ramsay AJ, Matthhaei KI, Young 1G. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse model. J Exp Med 1996;183:195-201.
29. Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-7.
30. van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, van Ark I, Delsman KC, Nijkamp FE Effect of anti-IL-5 and IL-S on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-52.
31. Mauser P3, Pitman AM, Fernandez X, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
32. Egan RW, Umland SP, Cuss FM, Chapman RW. Biology of interleukin-5 and its relevance to allergic disease. Allergy 1996;51:71-81.
33. Kopf M, Brombacher F, Hodgkin P, et al. IL-5 deficient mice have a developmental defect in CD5+ B-i cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996;5:81-9.
34. Lilly CM, Chapman RW, Sehring SJ, Mauser PJ, Egan RW, Drazen JM. Effects of interleukin-5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am 3 Physiol 1996;270:L368-75.
35. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. Am J Respir Cell Mol Biol 1997;99:1064-71.
36. Clutterbuck EK, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-i, IL-3, IL-6 and GM-CSF. Blood 1989;73:1504-12.
37. Inman MD, Denburg JA, Ellis R, Dahlback M, O'Byrne PM. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor. Am 3 Respir Cell Mol Biol 1996;15:305-il.
38. Sim TC, Grant IA, Hilsmeir KA, Fukuda Y, Alam R. Detection of proinflammatory cytokines in the nasal secretions of allergic subjects following antigen challenge. Am J Respir Crit Care Med 1994;149:339-44.
39. Jorgensen RK, Gleich GJ, Kita H, Reed CE. Topical glucocorticoid treatment of ragweed hay fever. I. Effects of IgE and IgA antibody production. I Allergy Clin Immunol 1997;99:S360.
40. Djukanovic R. Nasal polyps - a model of chronic respiratory mucosal inflammation. dim Exp Allergy 1995;25: 582-5.
41. Xaubet A, Mullol I, Lopez E, et al. Comparison of the role of nasal polyps and normal nasal mucosal epithelial cells on in vitro eosinophil survival mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994; 24:307-17.
42. Nutman TB, Ottesen EA, Cohen SG. The eosinophil, eosinophilia, and eosinophil-related disorders. Allergy Proc i989;10:33-46.
43. van Haelst Pisani C, Kovach IS, et al. Administration of interleukin 2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophiia in patients with cancer. Blood 1991;78:i538-44.
44. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992;77:494-9.
45. Weller PE The immunobiology of eosinophils. N EngI I Med 1991;324:iilO-14.
46. Yamaguchi 5, Nagai H, Tanaka H, Tsujimoto M, Tsuruoka N. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci i994;54:PL471-5.